The heat shock response (HSR) provides protec tion against stress-induced damage, and also prevents initiation of inflammatory gene expression via inhibition of NFKB acti vation. This article describes experiments demonstrating that the HSR prevents induction of nitric oxide synthase type 2 (NOS2) in rat brain. Twenty four hours after intrastriatal injec tion of lipopolysaccharide (LPS), IL-ll3, and IFN-'Y, NOS2 immunoreactive cells were detected in striatum, corpus callo sum, and to a lesser extent in cortex. Induction of a HSR by whole body warming to 41°C for 20 minutes, done 1 day before LPS plus cytokine injection, reduced the number of NOS2positive staining cells to background levels. Staining for EDI
antigen revealed that the HSR also suppressed microglial / brain macrophage activation in the same areas. Striatal injec tion of LPS and cytokines induced the rapid activation of NFKB, and this activation was prevented by prior HS, which also increased brain IKB-a expression. These results suggest that establishment of a HSR can reduce inflammatory gene expression in brain, mediated by inhibition of NFKB activation, and may therefore offer a novel approach to treatment and prevention of neurological disease and trauma. Key Words: Nitric oxide-Heat shock response-Inflammation Neurotoxicity-Cytokines. tricular injection of an IL-113 converting enzyme inhibitor reduced IL-113 expression and brain damage (Hara et aI., 1997) ; NOS2 enzyme inhibitors reduced cell loss in focal ischemia (Iadecola et aI., 1995) ; and stroke damage was less in homozygous ICAM-l knockout mice than in con trol littermates (Connolly et aI., 1996) . In experimental autoimmune encephalomyelitis, the animal model for multiple sclerosis, NOS2 inhibitors can ameliorate the development of symptoms (Cross et aI., 1994) ; and dis ease is more severe in mice lacking the anti inflammatory cytokine IL-IO (Bettelli et aI., 1998) . The anti-inflammatory actions of nonsteroidal anti inflammatory drugs reduce the risk of Alzheimer' s dis ease, possibly because of reduction in NOS2 expression (Flynn and Theesen, 1999) . These observations demon strate that suppression of inflammatory activation in brain will provide therapeutically beneficial effects.
The expression of numerous inflammatory genes is under control of transcription factor NFKB (Baeuerle and Henkel, 1994) , whose activation has been described dur ing neurological disease and trauma. Levels of NFKB are increased in brains with Alzheimer' s disease versus con trol brains (Kaltschmidt et aI., 1997; Kitamura et aI., 1997) during global (Clemens et aI., 1997) and transient (Gabriel et aI., 1999) forebrain ischemia in glial cells and neurons, in microglial cells after induction of experimen tal autoimmune encephalomyelitis (Kaltschmidt et aI., 1994) , in macrophages in human mUltiple sclerosis (Gv eric et aI., 1998) , and in neurons as a consequence of excitotoxic damage (Qin et aI., 1998) . In some cases the prevention of NFKB activation (Clemens et aI., 1998) was neuroprotective, suggesting that other methods to block NFKB activation in brain will also reduce inflam matory related damage.
It has been known for several years that the heat shock response (HSR) can protect cells and tissues from a va riety of noxious stimuli, including thermal, chemical, and physical stress, possibly by facilitating renaturation of partially denatured proteins or by chaperoning nascent proteins to specific subcellular locations. The HSR can protect animals against endotoxin lethality (Chu et aI., 1997; Hotchkiss et aI., 1993; Ribeiro et aI., 1994) and phospholipase-C-induced lung damage (Villar et aI., 1994) . Whether a HSR can protect the brain against in flammatory damage is not known. However, observa tions that HSPs are induced during stroke (Nowak and Jacewicz, 1994; Sharp et aI., 1993; Sharp et al.. 1999) , and that ischemic damage is reduced in transgenic mice constitutively expressing HSP70 in neurons and glia (Mestril et aI., 1994b; Plumier et aI., 1995; reviewed in Yenari et aI., 1999) suggests that a HSR will also be protective in the nervous system.
In addition to protecting against damage after insults, the HSR can prevent the initiation of inflammatory events themselves (Simon et aI., 1995; Snyder et aI., 1992) suggesting that in some cases the protective effects of HS are attributable to the prevention of proinflamma tory gene activation. We demonstrated that the HSR pre vents NOS2 induction by cytokines plus lipopolysaccha ride (LPS) in rat primary astrocytes, C6 glioma cells, and Rat-I fibroblasts (Feinstein et aI., 1996) , and similar re sults have been reported using rat pulmonary artery smooth muscle cells (Wong et aI., 1995) , human liver cells (de Vera et aI., 1996b), rat hepatocytes (de Vera et aI., 1996a), murine lung epithelial cells (Wong et aI., 1997a) , and cultured rat and human islets (Scarim et aI., 1998) . In whole animals, treatment with arsenite, which induces a HSR, blocked endotoxin-induced NOS2 ex pression in lung (Hauser et aI., 1996) . The HSR also prevents NFKB activation, due in part to the fact that the inhibitory IkB-a protein is a stress protein whose expres sion is increased by the HSR (Scarim et aI., 1998; De Meester et aI., 1997; Feinstein et aI., 1997; Meng et aI., 1999; Thomas et aI., 1998; Wong et aI., 1997; Wong et aI., 1999) . We now report that the HSR is an equally effective inhibitor of NFKB dependent inflammatory events in vivo, and demonstrate that a brief period of hyperthermia prevents subsequent NFKB activation, NOS2 expression, and microglial/macrophage activation induced by injection of LPS and cytokines into brain.
MATERIALS AND METHODS

Animals
Female Sprague-Dawley rats (Charles River, MA, U.S.A.) weighing 250 to 300 g, were housed in groups of 4 under standard conditions at 22°C and a 12-hour light-dark cycle with free access to food and water.
Experimental protocol
Rats were anesthetized with pentobarbital (50 mg/kg, dis solved in 0.9% sodium chloride) and placed into a heating blanket. Body temperature was monitored by a rectal probe connected to the heating blanket, and was raised gradually to 41 ± 0.5°C over a period of 5 minutes, then maintained for 20 minutes. Control animals were anesthetized but not heated. Females rats were used for all experiments since even brief (10 minutes at 41°C) hyperthermia increased the mortality rate of male, but not female rats. Intrastriata1 injections were per formed as previously described (Heneka et aI., 1999a) . After 24 hours recovery, rats were again anesthetized as described above and placed in a stereotaxic frame (David KOPF, CA, U.S.A.). Two fLL of a mixture containing recombinant rat IFN-)I (20 units/mL, Gibco, MD, U.S.A.), human IL-1[3 (10 ng/mL of 10 7 unit/mg, National Institutes of Health reagents program) and bacterial endotoxin LPS (I fLg/mL, Salmonella typhirium, Sigma, MO, U.S.A.) dissolved in phosphate buffered saline (PBS) (pH 7.4) was injected over a period of 120 seconds into the left striatum using a 5 fLL Hamilton syringe, at AP 0.0, L -3.0, V 6.0 mm relative to Bregma and 2 fLL of PBS were injected into the right striatum at AP 0.0, L+3.0, V 6.0. The needles were left in place for a further 5 minutes to prevent reflux up the needle tract. To maintain constant body tempera ture, animals were placed under a heating lamp until complete recovery from anesthesia. Either one or twenty-four hours after intrastriatal injection, animals were killed by an overdose of pentobarbital and then perfused transcardially with 200 mL heparinized sodium chloride (0.9%) and 200 mL fixative con taining 10% formaldehyde, 10% acetic acid and 80% methanol. Brains were removed, immersed in fixative for 72 hours at room temperature, then paraffin embedded. In some cases brains were removed without perfusion and protein lysates pre pared for immunoblot detection. All experiments were per formed in accordance with the declaration of Helsinski, the animal welfare guidelines and laws of the United States of America, and were approved by the local ethical committee for animal experiments.
Processing of brain tissue and immunohistochemistry
Serial coronal sections of whole brain were cut 8 fLm thick using a Leitz microtome and mounted on polY-L-lysine coated slides. Slides were immersed in 10 mmollL citrate buffer (pH 6.0) and heated in a microwave oven, 4 cycles of 5 minutes each, to unmask antigen sites. Slides were cooled for 20 min utes at room temperature, then washed in PBS. Endogenous peroxidase activity was inhibited by rinsing slides in 0.1 % hydrogen peroxide for 10 minutes. After washing in PBS, non specific binding was blocked by incubation in 10% normal goat serum in PBS for I hour at room temperature. After washing in PBS, sections were incubated overnight at 4°C with primary antibodies: (I) mAb N32020 directed against NOS2 (1: 200 dilution, Transduction Laboratories, KY, U.S.A.); (2) EDl mAb MCA 341 raised against rat lysosomal membrane antigen of activated macrophage/microglia (I :500 dilution, Serotec, Darmstadt, Germany); (3) rabbit polyclonal antibody SC-109 raised against NFKB subunit p65 (I :200 dilution, Santa Cruz, Heidelberg, Germany); (4) rabbit polyclonal antibody SC-I060 directed against HSP70 (I :300 dilution, Santa Cruz); or (5) rabbit polyclonal antibody SC-371 directed against IKB-a (Ll,500 dilution; Santa Cruz Biochemicals, Santa Cruz, CA, U.S.A.). The sections were washed extensively with PBS, then incubated with biotinylated anti-rabbit or anti-mouse IgG (1: 200 dilution, Vector Laboratories, Burlingame, CA, U.S.A.) for 30 minutes at room temperature. Immunohistochemical lo calization was performed using the avidin-biotin peroxidase complex method (ABC-Kit, Vector Laboratories) with 3,3' diaminobenzidine as chromogen.
Quantification of immunohistochemistry and statistical analysis
Quantitative analysis of NOS2 and ED I-antigen was per formed on brain sections from animals (6 heat shocked and 6 control) injected with LPS, IFNI', and IL-I � in saline, at 24 hours after injections. Antigens were detected in 7 sections having a defined distance relative to the level of intrastriatal injection. The sections were the middle section corresponding to the level of injection, with the injection site discernible, and the other 6 sections were taken at a distance of 25, 50, and 75 J..l m rostral and caudal of the injection site. Three different areas were defined and evaluated: striatum, corpus callosum, and cortex ipsilateral to the cytokine injection side. The number of cells within the respective fields was determined using a count ing grid. Data are shown as mean ± SD of the number of positive cells per mm2. Differences between controls and heat shocked animals were assessed by one way analysis of variance followed by a Tukey test (SYSTAT, Evanston, IL, U.S.A.).
Western Blot Analysis
Brain region extracts were prepared by sonication of dis sected brain regions (25 mg of wet weight tissue) in 10 volumes of 8 moUL urea. Aliquots were immediately mixed with SDS sample buffer, boiled, and either used immediately or frozen at -80°C. Twenty J..l g protein was separated through 10% poly acrylamide sodium dodecyl sulfate gels and proteins trans ferred by semidry blotting to polyvinylidene difluoride mem branes. The membranes were blocked in tris-buffered saline with 0.1 % TWEEN 20 containing 0.5% bovine serum albumin, washed, incubated with primary antibody to HSP70 (mAb SPA-81O, I: I ,000 dilution; Stressgen, Canada) or to the astro cyte-specific protein glial fibrillary acidic protein (mAb B2.210, Lee et aI., 1984) overnight at 4°C, washed extensively, incu bated with peroxidase conjugated goat anti-mouse IgG, then bands visualized with enhanced chemiluminescence reagents (Pierce, Rockford, IL, U.S.A.).
RESULTS
The efficacy of whole-body warming on inducing a HSR in brain was assessed by measuring levels of the inducible HSP70 protein 24 hours after increasing body temperature to 41°C for 20 minutes. Western blot analy sis indicated that in control (anesthetized only) animals, HSP70 was easily detectable in cortex, and present but at much lower levels in striatum ( Fig. I, top panel) . In both brain areas the antibody used, which is specific for the inducible HSP70 and does not cross react with constitu- tively expressed HSC70 (Manzerra et al.. 1997) , detected two bands of 68 to 70 kDa with comparable staining intensities. Heat shock greatly increased the levels of the slower migrating band in both brain areas, although higher levels were reached in cortex than striatum. The levels of the lower band were not significantly increased by HS. The levels of a third minor, faster migrating band (visible in cortex samples) was not effected by HS. Im munocytochemical staining for glial fibrillary acidic pro tein showed similar levels of this protein in control and heat shocked samples (Fig. 1, bottom panel) . Time course studies (not shown) revealed higher expression of HSP70 protein between 18 and 24 hours after HS com pared to either 4 hours or 48 hours after HS, and that a 20-minute HS was more effective than 10 minutes, but as effective as a 40-minute HS. We therefore chose 20 min utes of HS followed by 22 hours recovery for subsequent injection experiments.
Injection of a cytokine mixture (CM) containing bac terial endotoxin LPS together with cytokines (IFN-')' and TL-II3) induces inflammatory gene expression in brain (Kitamura et aI., 1996; Garcion et aI., 1998; Heneka et aI., 1999a) . Twenty four hours after intrastriatal injection of CM, numerous cells showed positive staining for NOS2 protein, with the highest number of positive cells observed in striatum, less in corpus callosum, and the fewest in cortex (Fig. 2) . When equivalent injections were made into striatum of animals that had been heat shocked one day earlier, the number of NOS2 staining cells was greatly reduced ( Fig. 2E ). Contralateral injec tion of saline did not induce any positive staining in either control (Fig. 2C ) or heat shocked animals (not shown). Injection of CM, but not PBS, into brain itself caused a slight increase in HSP70 expression that was
Heat shock prevents striatal nitric oxide synthase type 2 (NOS2) and ED1 expression. A mixture of lipopolysaccharide (LPS), IFN-,!, and IL-1[3 ("eM") in 2 j..I L total volume in saline was injected into the left striatum of control or heat-shocked animals (n = 3 each).
Saline alone was injected into the right striatum. After 24 hours, the animals were anesthetized, perfused, and sections stained for the presence of NOS2 (left panels) or ED1 (right panels). (A,S) eM injection into striatum of control animals; (C,D) Saline injection into striatum of control animals; (E,F) eM injection into striatum of heat-shocked animals. The staining was performed on sections obtained from three different animals in each group, with similar results.
restricted to the area around the needle tract (data not shown). Examination of serial sections through three brain regions ( Fig. 3) revealed that HS reduced the num ber of NOS2 staining cells at all distances from the lllJection site, with an overall reduction of greater than 90% (Fig. 3B ). The morphology of NOS2-positive cells was round to oval, resembling the typical morphology of brain macrophages and/or activated microglia. In addition, positive stammg cells were seen within and surrounding brain microvessels. These results demon strate that HS reduced eM-induced NOS2 staining in brain, and suggest that infiltrating monocytic cells con stitute a large portion of the NOS2-positive cells.
To determine if HS prevented macrophage or micro glial activation, we stained sections for EDI antigen 24 hours after intrastriatal eM injection (Figs. 2B, 2D , and 2F). As found for NOS2, LPS and cytokines induced a robust appearance of ED 1, with most cells having the appearance of activated macrophages or microglia (Fig.  2B) . The greatest numbers of ED I-positive staining cells were detected in striatum, with similar levels in corpus callosum, and lower levels in cortex. In all three brain regions, prior HS reduced staining for ED I to back ground levels ( Figs. 2F and 3) .
Since activation of transcription factor NFKB is nec essary for NOS2 induction, we tested the effects of HS on NFKB activation in brain (Fig. 4) . One hour after saline injection into the right striatum, and eM injection into the left striatum in both heat-shocked and control rats, the NFKB p65 subunit was detected by immunohis tochemistry. In the saline-injected hemisphere the NFKB p65 subunit was detected as a faint band of staining within the cytoplasm of parenchymal cells in both heat shocked and non-heat-shocked animals (Figs. 4D and 4E) . In contrast, injection of eM resulted in a marked change of the pattern of p65 staining, namely loss of the light cytoplasmic staining, and appearance of dense staining in smaller cells (Figs. 4A to 4C) . This change in staining pattern could be caused by increased p65 ex pression in a subpopulation of smaller cells, and/or to the movement of NFKB from a cytosolic to a nuclear loca tion. There were two morphologically distinct labeling patterns observed after LPS/cytokine stimulation, a round to oval morphology with no visible cytoplasm (Fig. 4B) , and a more uneven morphology with a lighter surrounding area (Fig. 4C ). The round morphology may be infiltrating monocytes, while the uneven staining may be parenchymal glial cells. The injection of eM into striatum of heat-shocked animals yielded a staining pat tern essentially the same as that following saline injec- FIG. 4. Heat shock prevents NFKB activation by lipopolysaccha ride (LPS) and cytokines. A mixture of LPS, IFN-,,/, and IL-1[3 ("CM") in 2 IJL total volume in saline was injected into the striatum of control or heat-shocked animals. Saline alone was injected into the contralateral striatum. After 1 hour, the animals were anes thetized, perfused, and sections stained for the presence of NFKB subunit p65. (A,S,C) CM injection into striatum of control animals; (D,E) saline injection into striatum of control animals; (F,G) CM injection into striatum of heat-shocked animals. Mag nification is 20 x in A, 0, and F, and 100 x in S, C, E, and G. The staining was performed on sections obtained from two different animals in each group, with similar results. tion (Figs. 4F and 4G); i.e. a lighter staining restricted to the cytoplasm of parenchymal cells. Saline injection into heat-shocked brain gave the same results as into non heat-shocked animals (data not shown). These results indicate that the HSR prevented the initial CM dependent NFKB activation in brain, which could ac count for the subsequent decrease in NOS2 and EDI staining observed.
The HSR has recently been shown to block NFKB activation because of increased expression of the inhibi tory IKB-a protein (Feinstein et aI., 1997; DeMeester et aI., 1997; Thomas et aI., 1998; Wong et aI., 1999) . We therefore tested if brain IKB-a protein levels were in creased by HS. Immunocytochemical staining of stria tum (Fig. 5 ) indicated low, basal levels of cytosolic IKB a. Twenty four hours after HS, IKB-a levels were greatly increased in cells throughout the striatum, with mor phologies similar to those identified by staining for NFKB. These results demonstrate that whole-body HS elevates brain IKB-a levels, and suggests that suppres sion of brain NFKB activation is mediated by increased IKB-a expression.
DISCUSSION
In this report we demonstrate for the first time that prior HSR, induced by whole-body hyperthermia, pre vents subsequent inflammatory reactions in rat brain caused by injection of bacterial endotoxin LPS and cy tokines. At 24 hours after intrastriatal injection of LPS, IL-l[3, and IFNI' ("CM"), we detected NOS2-positive cells in striatum, corpus callosum, and to a lesser extent in cortex. At the same time we also detected a large increase in ED I-positive staining cells, reflecting activa tion of resident microglial and/or infiltration of periph eral macrophages. Although injection of LPS alone (Gar cion et aI., 1998) or LPS plus IFNI' (Kitamura et aI., 1996) can induce NOS2, we found that injection of a combination of LPS, IL-l[3, and IFNI' to be a more re producible stimulus. Prior HS reduced the CM-induced appearance of both NOS2-and ED I-positive staining cells in all three brain regions examined. Heat shock prevented the rapid activation of NFKB that was ob served in non-heat-shocked animals at I hour after CM injection, supporting the idea that inhibition of brain NFKB activation contributes to the suppression of sub sequent inflammatory gene expression or activation. Heat shock also increased brain IKB-a levels, which could account for reduced NFKB activation. These re sults suggest that a controlled induction of a HSR in brain could reduce inflammatory damage during disease or trauma.
In our studies, we assessed the efficacy of whole body warming on inducing a HSR in brain by measuring changes in expression of HSP70. We found by western blot analysis that greater levels of HSP70 were attained between 18 and 24 hours after HS compared to either 4 or 48 hours after HS, and that 20 minutes of hyperther mia was more effective than 10 minutes, but as effective as 40 minutes. Although we have not determined the identity of HSP70 expressing cells, previous studies have shown that hyperthermia results in primarily glial (both astroglial and oligodendroglial) HSP70 expression (McCabe et a!., 1993; Foster et a!., 1997) , particularly at 24 hours after HS (Krueger et a!., 1999; Marini et a!., 1990) . Our findings (Fig. 5 ) that whole body hyperther mia increased expression of IKB-a in brain indicate that, as expected, other HSPs were induced by the paradigm used. Although optimization of IKB-a expression may have been a better method to assess the anti-inflamma tory role of the HSR, the anti-inflammatory effects we observed suggest that levels of HSP70 can be used as an effective index for studying anti-inflammatory effects of the HSR. Fortuitously, using a relatively short time of HS may have allowed for sufficient expression of anti inflammatory/ protective HSPs to occur while minimiz ing any damage due to excessive HS treatment.
Western blot analysis revealed two major 68 to 70 kDa HSP70 bands in control brain, of which one (of slower mobility) was greatly increased 24 hours after HS (Fig. 1) . The two bands most likely correspond to HSP70, since (1) the antibody used (mAb SPA-8 10 from Stressgen) does not detect the highly related HSC70 proteins (Manzerra et aI., 1997) ; (2) we did not observe strong staining in control striatum which is ex pected to express HSC70; and (3) basal expression of HSP70 in brain has previously been reported (Manzerra et a!., 1997; Longo et a!., 1993) . The observed hetero geneity of HSP70 may be caused by distinct mRNA species (Lowe and Moran, 1986; Blake et a!., 1990; Mestril et a!., 1994) , or multiple gene usage (see Longo et a!., 1993) . At least 4 distinct HSP70 proteins were detected in rabbit cerebellum, of which several, but not all, were greatly increased at 5 hours after HS (Manzerra et a!., 1997) . Our data similarly shows that whole body warming selectively increases some, but not all forms of HSP70 in rat brain.
Our results show that 24 hours after LPS and cytokine injection, numerous cells were stained for NOS2 pro tein. Strong NOS2 immunoreactivity was observed in areas around blood vessels, as well as in cells within vessel lumens, suggesting that at this time point the majority of NOS2 cells are infiltrating leukocytes, brain macrophages or activated microglia, as previously re ported (Kitamura et a!., 1996; Garcion et a!., 1998; Heneka et aI., 1999a) . Heat shock performed 24 hours before injection of immunostimulants prevented the ap pearance of NOS2-positive staining cells in all brain regions. In vitro studies have shown that the HSR blocks cytokine mediated NOS2 expression in lung epithelial cells (Wong et aI., 1997a) ; reduces ILl-[3 dependent nitrite accumulation and NOS2 mRNA expression in rat pulmonary artery smooth muscle cells (Wong et a!., 1995) ; prevents IL-l[3 stimulation of islet cell NOS2 (Scarim et a!., 1998) ; prevents cytokine-induced NOS2 expression in hepatocytes (de Vera et a!., 1996a,b); and prevents LPS-or cytokine-induced NOS2 expression in rat primary astrocytes, C6 glioma cells, and aortic smooth muscle cells (Feinstein et a!., 1996) . Our current studies therefore extend existing in vitro observations to an in vivo model of inflammation, and provide evidence that protection by HS in other animal models may be caused by reduction of NOS2 expression.
In parallel to reduced NOS2 expression, we also found that HS reduced the number of ED I-positive cells in brain induced by CM injection. The ED 1 antibody rec ognizes cells of the macrophage/monocyte lineage in rat (Dijkstra et aI., 1985) and in the CNS is specific for parenchymal microglia/brain macrophages and perivas cular microglial cells in various states of activation (Graeber et aI., 1990; Flaris et aI., 1993; Streit, 1995) . Because ED 1 labels monocytes/macrophages and acti vated microglia to a similar extent, these two cell types cannot be distinguished by this antibody. Most paren chymal cells detected were oval to round in shape, the characteristic morphology of brain macrophages and ac tivated microglia. Since cytokine injection causes re cruitment of blood monocytes into brain, it is likely that both an infiltration of blood derived monocytes together with activated resident microglia account for NOS2 and ED I positive staining in our model. In related studies (Heneka et aI., 2000) we found that the majority of NOS2-positive cells were also ED 1 positive, suggesting that CM injection does not induce significant astroglial NOS2 expression. Whether the HSR reduces levels of NOS2 and ED I staining in infiltrating monocyte by re ducing infiltration or by reducing activation once in the brain is not clear.
We have examined the effects of HS on brain NFKB activation after CM injection, since suppression of pa renchymal NFKB activation would be expected to block parenchymal cell NOS2 and ED I expression, as well as reduce blood monocyte infiltration caused by reduced expression of brain adhesion molecules and/or chemo kines. In saline-injected animals, faint staining for the p65 subunit was observed in large cells, and appeared to be primarily cytosolic. Basal p65 expression has previ ously been detected in neurons and resting astrocytes (Gabriel et a!., 1999; Kaltschmidt et aI., 1994) . One hour after injection of LPS and cytokines, the faint cytosolic staining was replaced by more intense p65 staining that was confined to smaller areas. This increased staining could be caused by movement of cytosolic p65 to the nucleus (thus accounting for loss of cytosolic immuno reactivity), and/or to increased p65 expression occurring in a second population of smaller cells (i.e., smaller glial versus larger neuronal cells, or infiltrating monocytes). The observation of two morphologically distinct staining patterns is consistent with activation of NFKB in multiple cell types. Prior HS prevented any changes in staining pattern observed for NFKB in brain, suggesting (1) that parenchymal cell NFKB activation was prevented; and (2) that NFKB activation in infiltrating cells was reduced, and/or there was suppression of monocyte infiltration into brain. These results are the first demonstration that the HSR is an effective inhibitor of NFKB activation in brain.
Whereas decreased NFKB activation in parenchymal glial cells could explain their lack of NOS2 (and ED I) expression, there are several ways by which reduced brain NFKB activation could suppression the inflamma tory state of infiltrating monocytes in brain. In vitro, a HSR blocked cell adhesion molecule (ICAM-l) expres sion in monocytes (Housby et aI., 1999) , and chemokine expression in epithelial cells (Ayad et aI., 1998) . It is therefore possible that in vivo, the decrease of brain NOS2 and EDI immunoreactivity is caused in part by reduced chemokine or adhesion molecule expression in resident cells, leading to a decrease in the number of invading cells. Alternatively, reduced proinflammatory cytokine expression from brain cells in response to the initial injection of immunostimulants, which normally activate and sustain NOS2 expression in infiltrating and resident cells, could contribute to reduced monocyte NOS2 and ED 1 expression. Finally, the HSR could re duce the ability of peripheral cells themselves to become activated, and thus lose the capacity to migrate into brain.
Previously studies have shown that the HSR can pro vide protection against various forms of inflammatory damage both in vitro and in vivo. Thus, prior hyperther mia decreased lung damage and mortality caused by in tratracheal instillation of phospholipase A2 (Villar et aI., 1994) ; and greatly increased survival after intravenous injection of endotoxin (Chu et aI., 1997; Hotchkiss et aI., 1993) . In vitro studies show that hyperthermia protects cultured cortical neurons from glutamate toxicity (Ror dorf et aI., 199 1); increases hippocampal survival in pri mary cultures (Sato et aI., 1996) ; and reduces cortical neuronal cell death from excitotoxic and apoptotic mechanisms (Snider et aI., 1998) . However, the protec tive role of the HSR, and HSP70 expression in ischemia is controversial. HSP70 mRNA is expressed in neurons and glia after ischemia (reviewed in Sharp et aI., 1999) ; however, within the infarct area translation into protein is limited (Nowak and Jacewicz, 1994; Kinouchi et aI., 1993) . HSP70 is also expressed in cells outside the in farct area (Kinouchi et aI., 1993) , and most cells which showed HSP70 staining showed little evidence for cell damage as indicated by DNA fragmentation (States et aI., 1998) . This suggests that ischemic stress can activate HSP70 expression in neurons distal from the infarct site, and that this expression provides protection against isch emic damage. In several models of ischemic tolerance, increases in HSP70 expression were found to parallel the degree of tolerance to subsequent ischemic damage (Kirino et aI., 199 1; Glazier et aI., 1994; Chen et ai., 1996) , although no correlation was observed between HSP70 expression and spreading depression induced tol erance (Kobayashi et aI., 1995) . More direct evidence that HSP70 expression provides protection against isch emic damage comes from transgenic studies in which constitutive HSP70 expression reduced ischemic dam age, both in heart and in brain (Mestril et aI., 1994; Plumier et aI., 1995; reviewed in Yenari et aI., 1999) . Together with our current results, these findings suggest that prior establishment of a HSR, and/or HSP70 expres sion, will prove effective in reducing inflammatory as well as ischemic damage in brain.
The mechanisms by which HS prevents inflammatory gene activation are not completely understood. Observa tions that the HSR reduced cytokine (Snyder et aI., 1992;  Ayad et a!., 1998) and NOS2 (Feinstein et aI., 1996; Wong et ai., 1995; de Vera et aI., 1996a,b; Scarim et aI., 1998; Hauser et aI., 1996) mRNA levels suggests that effects are mediated at the transcriptional level. This was confirmed in studies showing that the HSR reduced ac tivation of the NOS2 promoter transfected into hepato cytes (de Vera et aI., 1996a); C6 cells (Feinstein et ai., 1996) , and lung epithelial cells (Wong et aI., 1997 a) . Because activation of transcription factor NFKB is a gen eral activator of cytokines gene expression, the effects of HSR on NFKB activation have been studied. Heat shock prevented NFKB activation by IL-113 in islet cells (Scarim et a!., 1998) , by cytomix in hepatocytes (de Vera et aI., 1996a,b) , by LPS and cytomix in astrocytes and C6 cells (Feinstein et aI., 1996) , by TNF-cx in lung epi thelial cells (Wong et aI., 1997) , and by LPS in endo thelial cells (DeMeester et aI., 1997a) . It therefore ap pears that in vitro, the suppression of NOS2 by the HSR is mediated, at least in part, by inhibition of NFKB acti vation. However, additional mechanisms acting indepen dent of NFKB inhibition could also be activated by the HSR and contribute to decreased NOS expression, for example leading to decreased NOS2 mRNA stability or translational efficiency.
It is not clear how the HSR reduces NFKB activation. As we previously suggested (Feinstein et aI., 1997) , the presence of a nuclear localization site in HSP70 could allow it to compete with NFKB for access to the nuclear pore complex (Feinstein et aI., 1997) and thereby block NFKB nuclear uptake. Alternatively, cytosolic HSP70 could associate with the partially unfolded structure of the NFKB:IKB complex, thus preventing release of NFKB. The fact that HSP70 expression in transgenic mice reduced ischemic damage (Mestril et aI., 1994; Plumier et ai., 1995) suggests a direct effect of HSP70 on inflammatory damage. However, observations that the HSR prevented the cytokine-induced loss of TKB-cx in C6 J Cereh Blood Flow Metab, Va!. 20, No. 5, 2000 cells (Feinstein et aI., 1997) and epithelial cells (Wong et a!., 1997a,b) provides a further explanation for inhibition of NFKB activation, since IKB-cx degradation by the 26 proteasome is, in most cases, needed for release of NFKB and its migration to the nucleus, The HSR could increase IKB-cx levels directly since it was recently shown that IKB-cx is itself a stress protein whose promoter contains near-consensus binding sites for HS transcription factors (DeMeester et aI., 1997; Thomas et ai., 1998; Wong et a!., 1999) , or indirectly since the HSR can inhibit the activity of an IKB kinase (Curry et a!., 1999) . Our im munocytochemical data (Fig. 5) demonstrates that whole-body hyperthermia increases IKB-cx expression in brain, suggesting that IKB-cx functions as a stress protein both in vivo, as well as in vitro, and would therefore be expected to contribute to inhibition of NFKB activation.
Our results indicate that a brief period of prior hyper thermia can reduce subsequent inflammatory events in brain, suggesting a possible therapeutic application for the HSR in the prevention or reduction of inflammatory damage in brain. In a related set of studies (Heneka et aI., unpublished observations, 1999) we found that intracer ebellar injection of LPS, IL-II3, and IFN-)" the same cytokine combination as used in the present study, in duced both NOS2 expression as well as apoptotic cell death in cerebellar granule cells. Similarly, intrahippo campal injection of LPS (Garcion et a!., 1998) or LPS plus IFN-)' caused neuronal ap optosis as assessed by TUNEL staining. Since in vitro, inhibition of NOS2 expression by selective NOS2 inhibi tors can prevent neuronal apoptosis (Heneka et aI., 1998) it is likely that inflammatory induction of NOS2 in brain contributes to eventual cell death. Our findings therefore suggest that prior establishment of a HSR in brain will prevent neuronal cell death, as well as acute inflamma tory activation.
Because hyperthermia itself cannot be considered a practical therapeutic approach, alternative means to in duce a HSR in brain must be considered. The observa tions that nonsteroidal anti-inflammatory drugs including indomethacin and ibuprofen, inhibit NOS2 expression (Aeberhard et aI., 1995) and NFKB activation (D' Acquisto et a!., 1998; Fiebich et aI., 1999; Lee et a!., 1995; Scheuren et aI., 1998) , together with findings that these same drugs induce a HSR (Housby et aI., 1999; Lee et aI., 1995; Fawcett et a!., 1997) suggest that the mecha nism of action of nonsteroidal anti-inflammatory drugs may be mediated, at least partly, through the HSR. Simi larly, anti-inflammatory prostaglandins, including PGA1 (Rossi et aI., 1997) and PGJ2, an endogenous agonist of the peroxisome proliferator-activated receptor-), (Col ville-Nash et aI., 1998; Petrova et aI., 1999; Ricote et ai., 1998; Jiang et a!., 1998; Heneka et ai., 1999b) , block both NOS2 expression and NFKB activation, and also induce a HSR (Rossi et a!., 1997; Colville-Nash et aI., 1998; Amici et aI., 1992; Kitamura et aI., 1999) . Finally, the knowledge that treatment with aspirin or indometh acin lowers the threshold for inducing a HSR (Lee et aI., 1995) suggests that a combination of anti-inflammatory drug treatment with mildly elevated temperature (i.e., 39°C) could prove effective in reducing inflammatory damage. These findings raise the possibility that phar macologic treatments can be used to induce a HSR under normothermic conditions.
